of GATA-3 during lymphocyte differentiation and mouse embryogenesis. Dev Immunol 3:1–11.
Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld
FG, Engel JD, Lindenbaum MH (1995) Targeted disruption of the
GATA3 gene causes severe abnormalities in the nervous system and in
fetal liver haematopoiesis. Nat Genet 11:40 – 44.
Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin
SH, Costantini F (1991) Erythroid differentiation in chimaeric mice
blocked by a targeted mutation in the gene for transcription factor
GATA1. Nature 349:257–260.
Puizillout JJ, Gaudin-Chazal G, Sayadi A, Vigier D (1981) Serotoninergic mechanisms and sleep. J Physiol (Paris) 77:415– 424.
Roberts MH, Davies M, Girdlestone D, Foster GA (1988) Effects of
5-hydroxytryptamine agonists and antagonists on the responses of rat
spinal motoneurones to raphe obscurus stimulation. Br J Pharmacol
95:437– 448.
Simon MC (1995) Gotta have GATA. Nat Genet 11:9 –11.
Stockmeier CA (1997) Neurobiology of serotonin in depression and suicide. Ann NY Acad Sci 836:220–232.
To ̈rk I (1990) Anatomy of the serotonergic system. Ann N Y Acad Sci
600:9 –34.
Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW,
Orkin SH (1994) An early haematopoietic defect in mice lacking the
transcription factor GATA2. Nature 371:221–226.
Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ,
Crossley M, Orkin SH (1997) FOG, a multitype zinc finger protein,
acts as a cofactor for transcription factor GATA1 in erythroid and
megakaryocytic differentiation. Cell 90:109–119.
